Fatty liver deposition and sparing: a pictorial review by Patrick-Olivier Décarie et al.
PICTORIAL REVIEW
Fatty liver deposition and sparing: a pictorial review
Patrick-Olivier Décarie & Luigi Lepanto & Jean-Sébastien Billiard & Damien Olivié &
Jessica Murphy-Lavallée & Claude Kauffmann & An Tang
Received: 8 February 2011 /Revised: 17 March 2011 /Accepted: 9 June 2011 /Published online: 28 June 2011
# European Society of Radiology 2011
Abstract
Objective Fatty liver deposition is a very common finding, but
it has many atypical patterns of distribution that can represent
diagnostic pitfalls. The purpose of this pictorial essay is to
review different patterns of fatty liver deposition and sparing.
Methods We searched our archive retrospectively, reviewed
the literature, and identified six patterns of liver steatosis.
Results Steatosis may be diffuse, geographic, focal, subcap-
sular, multifocal or perivascular.
Conclusions Previous knowledge of atypical patterns of
steatosis distribution may prevent misdiagnosis of infiltrative
disease or focal liver lesions. When an unusual form of fatty
liver deposition is suspected on ultrasound or computed
tomography, magnetic resonance imaging may be used to
confirm the diagnosis.
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Introduction
Fatty liver disease is a very common condition, with a
prevalence of 20–30% in the adult population [1] and 70%
in diabetes patients [2]. Among patients who develop non-
alcoholic steatohepatitis (NASH), half will evolve to
fibrosis, 10–15% to cirrhosis and 5.4% to hepatic insuffi-
ciency [1]. Radiologists must report fatty liver disease
because it may have serious long-term consequences if left
untreated. Recent trials have shown histological improve-
ments of steatosis and NASH after a medical treatment [3].
Fatty liver may present with different patterns of deposition
and sparing. We searched our archive retrospectively,
reviewed the literature and identified six patterns of liver
steatosis: diffuse, geographic, focal, subcapsular, multifocal
and perivascular. Diffuse forms may be graded subjectively
according to severity (mild, moderate, severe) or quantita-
tively with magnetic resonance (MR)-based methods [4].
Some unusual focal forms may be misdiagnosed as
infiltrative or nodular liver lesions. Therefore, previous
knowledge of their cross-sectional appearance may prevent
unwarranted investigations or allow non-invasive diagnosis.
Ultrasound is the first-line imaging technique for the
screening and follow-up of patients with chronic liver
disease. It is, therefore, important for radiologists to be
aware of patterns of heterogeneous or focal forms of fatty
deposition. On ultrasound, fatty liver is hyperechoic
compared with renal cortex and spleen, whereas fatty
sparing is isoechoic or hypoechoic.
On unenhanced computed tomography (CT), liver
density less than 40 Hounsfield units (HU) [5] or a density
difference of more than 10 HU between spleen and liver
indicates fatty liver [6]. Alternatively, liver parenchyma
hypodensity relative to vessels establishes the presence of
moderate to severe fatty liver disease [7]. On portal phase
contrast-enhanced CT with a standardised protocol, a
density difference greater than 25 HU between spleen and
liver suggests fatty liver deposition [6]. CT with contrast
material was previously thought to be less reliable in
detecting fatty liver. However, recent data suggest that
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portal phase contrast-enhanced CT using blood-subtracted
hepatic attenuation may have a similar accuracy to or even
greater accuracy than unenhanced CT in the diagnosis of
fatty liver [8].
MR imaging (MRI) allows measurement of fat and water
proton signals and is considered the most accurate non-
invasive technique for hepatic fat quantification [4].
Chemical shift gradient-echo imaging is a widely available
MRI technique for fat detection and quantification. Fatty
liver shows a signal drop on gradient echo T1-weighted
out-of-phase images compared with in-phase images [7].
The dual-echo method results in underestimation of the fat
fraction by only 2.9% compared with spectroscopy, the
non-invasive “gold standard” [9].
Diffuse fat deposition
Diffuse fatty liver deposition is the most prevalent form of
fatty liver disease. The liver is homogeneously involved by fat
accumulation (Fig. 1). It may have different levels of severity
that can be determined by using quantification maps. The
presence of diffuse steatosis in a patient with hepatomegaly
and an enlarged caudate-to-right lobe ratio should raise the
possibility of NASH [10].
Fig. 1 a–d Severe diffuse fatty
liver disease. a Ultrasound image
in a 58-year-old man known for
intraductal papillary mucinous
neoplasm (IPMN/IPMT) of the
pancreas and alcoholic pancrea-
titis showing a hyperechoic liver
compared with the right renal
cortex. b CT, axial contrast-
enhanced portal phase image
shows a diffusely hypodense
liver (42 HU) compared with the
spleen (113 HU) (>25 HU dif-
ference). MRI, c axial T1-
weighted in-phase and d out-of-
phase images show an important
signal drop of the liver on the
opposed-phase image. MR
images were obtained on a 1.5-T
MRI system with TEs of 2.2 and
4.5 for in- and out-of-phase
images respectively
Fig. 2 a, bGeographic fat accu-
mulation limited to the right
lobe of the liver. MRI of the
liver in a 57-year-old woman
known for multiple focal nodu-
lar hyperplasia. a Axial T1-
weighted in-phase and b out-of-
phase images show an important
signal drop in the right lobe of
the liver on opposed-phase im-
age
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Fig. 3 a–c Severe geographic
fatty liver deposition. MRI of
the liver in a 76-year-old man
who had hepatico-jejunostomy
for biliary duct trauma and
stenosis followed by two epi-
sodes of cholangitis in 1997 and
2006. a Axial T1-weighted in-
phase and b out-of-phase images
show an important signal drop
on the opposed-phase image in a
geographic distribution, affect-
ing the hepatic dome more se-
verely. c Subtraction confirms
severe geographic fatty liver
deposition
Fig. 4 Focal fatty liver deposi-
tion. a CT, axial contrast-
enhanced portal phase image in
a 58-year-old woman shows a
hypodense, mildly heteroge-
neous, cuneiform lesion in the
posterior aspect of segment IV.
MRI, b axial T1-weighted in-
phase and c out-of-phase images
show a signal drop within this
lesion on the opposed-phase
image
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Geographic fat deposition
Geographic fatty liver disease is a frequently encountered
variant. Different geographic patterns can be attributed to
specific causes. For example, fat accumulation sometimes
occurs only in the right lobe (Fig. 2). One hypothesis to
explain this distribution is that blood from the superior
mesenteric vein containing lipogenic alimentary factors is
preferentially distributed to the right lobe of the liver
[11]. Geographic patterns may be secondary to an insult to
the liver parenchyma. For example, fatty liver deposition
can be distributed in territories previously affected by
cholangitis (Fig. 3).
Focal fat deposition and focal fatty sparing
Focal fat deposition is slightly less common and can mimic
other hepatic benign or malignant lesions on ultrasound and
CT (Fig. 4). MRI is very useful for making the diagnosis of
focal hepatic steatosis, which appears isointense or hyper-
intense to liver on in-phase images and loses signal on out-
of-phase images. Fat accumulation does not show diffusion
Fig. 5 a–d Perivesicular fatty
sparing. a Ultrasound image in a
77-year-old woman who had
nephrectomy for renal cell
carcinoma shows a hyperechoic
liver with hypoechoic perivesic-
ular foci. b CT, axial contrast-
enhanced portal phase image
shows a diffusely hypodense
liver (57 HU) in comparison
with the spleen (135 HU) with a
perivesicular spared zone (in
segments IV and V). MRI, c
axial T1-weighted in-phase and
d out-of-phase images show an
important signal drop of the
liver on the opposed-phase
image with the exception of a
perivesicular spared zone
Fig. 6 a–c Subcapsular fatty
liver deposition. a Axial
contrast-enhanced portal phase
CT image in a 58-year-old man
with a neuro-endocrine tumour
of the pancreas shows two small
hypodense subcapsular hepatic
lesions in segment V. MRI, b
axial T1-weighted in-phase and
c out-of-phase images show a
drop of signal within the two
subcapsular lesions on the
opposed-phase image
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restriction, which may also be useful to differentiate
steatosis from other liver abnormalities. Moreover, focal
fat accumulation tends to show wedge–shaped margins, no
mass effect on adjacent blood vessels or the biliary tree,
sharp boundaries, and lobar or segmental distribution [12].
Some regions of the liver are more prone to being
affected by focal fat deposition. The same regions corre-
spond to spared areas in diffuse fat deposition (Fig. 5).
Those are the perivesicular and subcapsular regions
abutting the hepatic hilum or falciform ligament in the area
drained by the Sapey’s vein [7, 11]. The classical patterns
of focal fatty liver deposition and sparing are linked to
vascular anatomical variants that involve capsular veins,
peribiliary veins, the cystic vein (which drains perivesicular
areas), and the right gastric vein (which drains the anterior
portion of segment I and the posterior portion of segment
IV). These veins can be the source of an aberrant venous
draining system without portal inflow causing local
haemodynamic anomalies that may lead to focal fatty liver
deposition and sparing [11, 13].
Subcapsular fat deposition
Subcapsular fat deposition may present as small fat nodules
(Fig. 6) or as a confluent peripheral region of fat confined
to a subcapsular zone [7]. It may be caused by insulin
added to the peritoneal dialysate in certain patients with
renal failure and insulin-dependent diabetes. Subcapsular
Fig. 7 a–d Multifocal fatty liver
deposition. a Ultrasound
image in a 39-year-old woman
with lymphoma and malignant
thymoma with local pleural
recurrence treated with radio-
therapy and chemotherapy shows
multiple nodular hyperechoic
foci throughout the liver. b CT,
axial unenhanced image shows
multiple hypodense foci
throughout the liver. MRI, c axial
T1-weighted in-phase and d out-
of-phase images show multiple
lesions with signal drop on the
opposed-phase image
Fig. 8 a, b Perivascular fatty
sparing. a Ultrasound image in a
39-year-old man with a clinical
suspicion of non-alcoholic fatty
liver disease based on elevated
liver enzymes shows a
geographic area of fatty sparing
parallel to the right hepatic vein.
b Doppler image shows an
absence of mass effect on the
right hepatic vein
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hepatocytes are exposed to a higher concentration of insulin
than the rest of the liver in those patients. Because insulin
promotes the esterification of free fatty acids into trigly-
cerides, the peritoneal administration of insulin can result in
subcapsular fat accumulation [14]. This form of fatty liver
deposition may also be idiopathic.
Multifocal fat deposition
Multifocal fatty liver deposition is another unusual pattern
that can represent a difficult diagnostic challenge. This
entity has also been described as multinodular hepatic
steatosis [15]. Multiple fat foci are randomly distributed
throughout the liver. The foci are usually round or oval and
may mimic multiple nodules. The differential diagnosis on
CT and ultrasound may include metastasis, lymphoma,
sarcoidosis, abscesses, candidiasis, haemangiomatosis and
biliary hamartomas. MRI is usually required to make the
diagnosis (Fig. 7). The pathogenesis of multifocal fat
deposition is unknown.
Perivascular fat deposition and perivascular fatty sparing
A very unusual pattern of fatty liver disease is perivascular
deposition. Halos of fat surround the hepatic veins, the
portal veins, or both hepatic and portal veins [7].
Perivascular fatty sparing can also be seen (Fig. 8). It may
be difficult to differentiate perivascular fat deposition or
perivascular sparing from periportal oedema, passive
hepatic congestion and Budd–Chiari syndrome on CT and
ultrasound. MRI is useful for making this rare diagnosis by
showing a signal intensity loss on opposed-phase images
compared with in-phase images. The pathogenesis of
perivascular fat deposition and sparing is unknown.
Conclusion
Fatty liver deposition is a very common finding but it has
many atypical patterns of distribution that can represent
diagnostic pitfalls. Steatosis may be diffuse, geographic,
focal, subcapsular, multifocal or perivascular. When an
atypical form of fatty liver deposition is suspected on
ultrasound or CT, MRI may be used to confirm the
diagnosis because of its ability to break down fat and water
signal components.
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